114 related articles for article (PubMed ID: 8978736)
1. Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues.
Heyes MP; Morrison PF
J Neurochem; 1997 Jan; 68(1):280-8. PubMed ID: 8978736
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
Saito K; Nowak TS; Markey SP; Heyes MP
J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
[TBL] [Abstract][Full Text] [Related]
3. Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis.
Beagles KE; Morrison PF; Heyes MP
J Neurochem; 1998 Jan; 70(1):281-91. PubMed ID: 9422373
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
[TBL] [Abstract][Full Text] [Related]
5. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.
Saito K; Crowley JS; Markey SP; Heyes MP
J Biol Chem; 1993 Jul; 268(21):15496-503. PubMed ID: 8340378
[TBL] [Abstract][Full Text] [Related]
6. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain.
Kita T; Morrison PF; Heyes MP; Markey SP
J Neurochem; 2002 Jul; 82(2):258-68. PubMed ID: 12124427
[TBL] [Abstract][Full Text] [Related]
7. Temporal and spatial changes of quinolinic acid immunoreactivity in the gerbil hippocampus following transient cerebral ischemia.
Barattè S; Molinari A; Veneroni O; Speciale C; Benatti L; Salvati P
Brain Res Mol Brain Res; 1998 Aug; 59(1):50-7. PubMed ID: 9729272
[TBL] [Abstract][Full Text] [Related]
8. Changes in quinolinic acid production and its related enzymes following D-galactosamine and lipopolysaccharide-induced hepatic injury.
Ohashi H; Saito K; Fujii H; Wada H; Furuta N; Takemura M; Maeda S; Seishima M
Arch Biochem Biophys; 2004 Aug; 428(2):154-9. PubMed ID: 15246871
[TBL] [Abstract][Full Text] [Related]
9. Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis.
Morrison PF; Morishige GM; Beagles KE; Heyes MP
J Neurochem; 1999 May; 72(5):2135-44. PubMed ID: 10217295
[TBL] [Abstract][Full Text] [Related]
10. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.
Chiarugi A; Moroni F
Neuropharmacology; 1999 Aug; 38(8):1225-33. PubMed ID: 10462134
[TBL] [Abstract][Full Text] [Related]
11. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
Front Immunol; 2020; 11():31. PubMed ID: 32153556
[TBL] [Abstract][Full Text] [Related]
12. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
[TBL] [Abstract][Full Text] [Related]
14. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
15. Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation.
Heyes MP; Saito K; Chen CY; Proescholdt MG; Nowak TS; Li J; Beagles KE; Proescholdt MA; Zito MA; Kawai K; Markey SP
J Neurochem; 1997 Oct; 69(4):1519-29. PubMed ID: 9326281
[TBL] [Abstract][Full Text] [Related]
16. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.
Saito K; Markey SP; Heyes MP
Neurosci Lett; 1994 Sep; 178(2):211-5. PubMed ID: 7824198
[TBL] [Abstract][Full Text] [Related]
17. Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations.
Heyes MP; Markey SP
Anal Biochem; 1988 Oct; 174(1):349-59. PubMed ID: 2975477
[TBL] [Abstract][Full Text] [Related]
18. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.
Heyes MP; Saito K; Lackner A; Wiley CA; Achim CL; Markey SP
FASEB J; 1998 Jul; 12(10):881-96. PubMed ID: 9657528
[TBL] [Abstract][Full Text] [Related]
19. Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates increases in brain quinolinic acid during CNS-localized and systemic immune activation.
Koennecke LA; Zito MA; Proescholdt MG; van Rooijen N; Heyes MP
J Neurochem; 1999 Aug; 73(2):770-9. PubMed ID: 10428075
[TBL] [Abstract][Full Text] [Related]
20. On the production and disposition of quinolinic acid in rat brain and liver slices.
Speciale C; Schwarcz R
J Neurochem; 1993 Jan; 60(1):212-8. PubMed ID: 8417142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
